![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://johnsonandjohnson.gcs-web.com/static-files/4120e707-3112-4f0b-a1d2-7015893e855c
https://news.bms.com/news/details/2023/The-Bristol-Myers-Squibb-Janssen-Collaboration-Launches-Pivotal-Phase-3-Librexia-Clinical-Trial-Program-Evaluating-Milvexian-an-Investigational-Oral-Factor-XIa-Inhibitor/default.aspx
https://www.fiercepharma.com/pharma/johnson-johnson-ceo-duato-points-out-5-pipeline-meds-can-generate-5b